Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations
Clinical trial NCT02304809 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02304809
- Sponsor
- UNICANCER
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2019-05-07
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.